259 related articles for article (PubMed ID: 26043170)
1. Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment.
Tientcheu LD; Maertzdorf J; Weiner J; Adetifa IM; Mollenkopf HJ; Sutherland JS; Donkor S; Kampmann B; Kaufmann SH; Dockrell HM; Ota MO
Genes Immun; 2015; 16(5):347-55. PubMed ID: 26043170
[TBL] [Abstract][Full Text] [Related]
2. Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
Tientcheu LD; Haks MC; Agbla SC; Sutherland JS; Adetifa IM; Donkor S; Quinten E; Daramy M; Antonio M; Kampmann B; Ottenhoff TH; Dockrell HM; Ota MO
PLoS Negl Trop Dis; 2016 May; 10(5):e0004701. PubMed ID: 27192147
[TBL] [Abstract][Full Text] [Related]
3. Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota.
Namasivayam S; Diarra B; Diabate S; Sarro YDS; Kone A; Kone B; Tolofoudie M; Baya B; Diakite MT; Kodio O; Cohen K; Holl J; Achenbach CJ; Chatterjee S; Murphy RL; Bishai W; Diallo S; Sher A; Maiga M
PLoS Negl Trop Dis; 2020 May; 14(5):e0008230. PubMed ID: 32401750
[TBL] [Abstract][Full Text] [Related]
4. Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients.
Tientcheu LD; Sutherland JS; de Jong BC; Kampmann B; Jafali J; Adetifa IM; Antonio M; Dockrell HM; Ota MO
Eur J Immunol; 2014 May; 44(5):1387-98. PubMed ID: 24481948
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis.
Ma S; Jaipalli S; Larkins-Ford J; Lohmiller J; Aldridge BB; Sherman DR; Chandrasekaran S
mBio; 2019 Nov; 10(6):. PubMed ID: 31719182
[TBL] [Abstract][Full Text] [Related]
6. Association of
Baya B; Diarra B; Diabate S; Kone B; Goita D; Sarro YDS; Cohen K; Holl JL; Achenbach CJ; Tolofoudie M; Togo ACG; Sanogo M; Kone A; Kodio O; Dabitao D; Coulibaly N; Siddiqui S; Diop S; Bishai W; Dao S; Doumbia S; Murphy RL; Diallo S; Maiga M
Am J Trop Med Hyg; 2020 Jan; 102(1):36-41. PubMed ID: 31733052
[No Abstract] [Full Text] [Related]
7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
Subbian S; Tsenova L; O'Brien P; Yang G; Koo MS; Peixoto B; Fallows D; Dartois V; Muller G; Kaplan G
PLoS Pathog; 2011 Sep; 7(9):e1002262. PubMed ID: 21949656
[TBL] [Abstract][Full Text] [Related]
9. Expression of nuclear factor, erythroid 2-like 2-mediated genes differentiates tuberculosis.
Qian Z; Lv J; Kelly GT; Wang H; Zhang X; Gu W; Yin X; Wang T; Zhou T
Tuberculosis (Edinb); 2016 Jul; 99():56-62. PubMed ID: 27450006
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
Marimani M; Ahmad A; Duse A
Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
[TBL] [Abstract][Full Text] [Related]
12. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
Kiran D; Podell BK; Chambers M; Basaraba RJ
Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Multi-Drug Resistant
Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of serum bradykinin and desArg
Qian X; Nguyen DTM; Li Y; Lyu J; Graviss EA; Hu TY
Tuberculosis (Edinb); 2016 Dec; 101S():S109-S118. PubMed ID: 27720377
[TBL] [Abstract][Full Text] [Related]
15. Comparative genomics shows differences in the electron transport and carbon metabolic pathways of Mycobacterium africanum relative to Mycobacterium tuberculosis and suggests an adaptation to low oxygen tension.
Ofori-Anyinam B; Riley AJ; Jobarteh T; Gitteh E; Sarr B; Faal-Jawara TI; Rigouts L; Senghore M; Kehinde A; Onyejepu N; Antonio M; de Jong BC; Gehre F; Meehan CJ
Tuberculosis (Edinb); 2020 Jan; 120():101899. PubMed ID: 32090860
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles classifying clinical stages of tuberculosis and monitoring treatment responses in Ethiopian HIV-negative and HIV-positive cohorts.
Gebremicael G; Kassa D; Alemayehu Y; Gebreegziaxier A; Kassahun Y; van Baarle D; H M Ottenhoff T; M Cliff J; C Haks M
PLoS One; 2019; 14(12):e0226137. PubMed ID: 31821366
[TBL] [Abstract][Full Text] [Related]
17. Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.
Asalla S; Mohareer K; Banerjee S
Front Cell Infect Microbiol; 2017; 7():439. PubMed ID: 29067283
[No Abstract] [Full Text] [Related]
18. The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to
Lugo-Villarino G; Troegeler A; Balboa L; Lastrucci C; Duval C; Mercier I; Bénard A; Capilla F; Al Saati T; Poincloux R; Kondova I; Verreck FAW; Cougoule C; Maridonneau-Parini I; Sasiain MDC; Neyrolles O
Front Immunol; 2018; 9():1123. PubMed ID: 29946317
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Diriba G; Kebede A; Tola HH; Yenew B; Moga S; Addise D; Alemu A; Mohammed Z; Getahun M; Fantahun M; Tadesse M; Dagne B; Amare M; Assefa G; Abera D; Desta K
PLoS One; 2020; 15(12):e0243493. PubMed ID: 33284842
[TBL] [Abstract][Full Text] [Related]
20. Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism.
Kim H; Shin SJ
Cell Mol Life Sci; 2023 Sep; 80(10):291. PubMed ID: 37704889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
